EA
SGNT

Emerald Acquisition’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Emerald Acquisition’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-524,293
Closed -$7.85M – 3152
2016
Q2 		$7.85M Buy
+524,293
New +$6.74M 0.01% 1058

Emerald Acquisition's SGNT Position: Q3 2016 in Review

Emerald Acquisition sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 524,293 shares — an estimated $7.85M sold.

Emerald Acquisition first reported a position in SGNT in Q2 2016 and held it in 1 quarter. The position peaked at $7.85M in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Emerald Acquisition reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Emerald Acquisition sold 524,293 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $7.85M.
  • Emerald Acquisition first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2016 and held it in 1 quarter.
  • Emerald Acquisition's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $7.85M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.